Tocqueville Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,875	Closed	-$208K	–	705
2019 Q4	$208K	Sell	2,875 -46,990	-94%	-$5.78M	﹤0.01%	700
2019 Q3	$7M	Sell	49,865 -11,880	-19%	-$1.99M	0.09%	216
2019 Q2	$11.3M	Sell	61,745 -780	-1%	-$133K	0.15%	176
2019 Q1	$9.95M	Sell	62,525 -19,360	-24%	-$2.8M	0.13%	186
2018 Q4	$7.84M	Sell	81,885 -4,565	-5%	-$522K	0.12%	194
2018 Q3	$12.2M	Sell	86,450 -10,845	-11%	-$1.67M	0.15%	171
2018 Q2	$15.2M	Buy	97,295 +40,940	+73%	+$6.43M	0.19%	137
2018 Q1	$9.08M	Buy	56,355 +19,055	+51%	+$3.24M	0.12%	194
2017 Q4	$6.14M	Sell	37,300 -21,600	-37%	-$2.09M	0.07%	278
2017 Q3	$3.67M	Sell	58,900 -12,550	-18%	-$986K	0.04%	370
2017 Q2	$5.69M	Buy	71,450 +10,400	+17%	+$752K	0.07%	276
2017 Q1	$4.34M	Sell	61,050 -2,000	-3%	-$117K	0.05%	312
2016 Q4	$3.22M	Buy	63,050 +18,675	+42%	+$880K	0.04%	352
2016 Q3	$2.04M	Buy	44,375 +4,850	+12%	+$197K	0.02%	407
2016 Q2	$1.19M	Hold	39,525	–	–	0.01%	484
2016 Q1	$1.27M	Buy	39,525 +650	+2%	+$22.9K	0.02%	467
2015 Q4	$2.27M	Buy	38,875 +5,775	+17%	+$286K	0.03%	401
2015 Q3	$1.4M	Buy	33,100 +10,400	+46%	+$641K	0.02%	492
2015 Q2	$1.66M	Buy	22,700 +6,325	+39%	+$407K	0.02%	485
2015 Q1	$823K	Buy	+16,375	New	+$704K	0.01%	621